In pancreatic cancer, RIPK4 can promote cell migration and invasion via the phosphatidylethanolamine binding protein 1 (PEBP1) degradation-induce activation of the RAF1/MEK/ERK signaling pathway (Qi et al., 2018). Here, RIPK4 is linked to familial pancreatic carcinoma.